Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	575	125	589	2,339	4,749	2,785
Market Cap Growth	-74.57%	-78.87%	-74.81%	-50.75%	70.51%	-7.78%
Enterprise Value	1,402	873	1,352	2,603	5,002	3,428
PE Ratio	-	-0.16	-2.78	10.65	15.53	51.10
PS Ratio	0.48	0.12	0.53	1.32	3.01	2.52
PB Ratio	0.87	0.19	0.43	1.45	3.28	2.56
P/FCF Ratio	-1.00	-0.48	-3.93	24.34	12.02	27.55
P/OCF Ratio	-1.56	-0.60	-17.28	7.30	8.84	14.81
EV/Sales Ratio	1.18	0.83	1.21	1.47	3.17	3.10
EV/EBITDA Ratio	-2.77	-1.68	-35.22	5.64	8.97	15.14
EV/EBIT Ratio	-2.07	-1.36	-7.44	7.71	11.29	29.61
EV/FCF Ratio	-7.25	-3.39	-9.02	27.09	12.66	33.91
Debt / Equity Ratio	1.36	1.32	1.01	0.52	0.60	0.75
Debt / EBITDA Ratio	-2.62	-1.66	-36.61	1.82	1.57	3.58
Debt / FCF Ratio	-6.85	-3.34	-9.38	8.75	2.21	8.02
Quick Ratio	0.50	0.46	0.65	2.29	2.22	2.03
Current Ratio	1.08	1.04	0.99	3.40	3.11	3.17
Asset Turnover	0.62	0.48	0.39	0.61	0.62	0.48
Interest Coverage	-4.92	-7.32	-4.87	9.79	14.16	3.02
Return on Equity (ROE)	-76.20%	-86.80%	-14.30%	14.20%	24.60%	5.30%
Return on Assets (ROA)	-29.40%	-34.40%	-7.30%	7.50%	11.90%	2.40%
Return on Capital (ROIC)	-34.34%	-48.12%	-6.09%	10.08%	14.02%	4.23%
Earnings Yield	-98.32%	-610.73%	-35.91%	9.39%	6.44%	1.96%
FCF Yield	-23.00%	-207.11%	-25.44%	4.11%	8.32%	3.63%
Buyback Yield / Dilution	-3.98%	-2.20%	7.39%	-0.56%	-2.67%	-1.95%
Total Shareholder Return	-3.98%	-2.20%	7.39%	-0.56%	-2.67%	-1.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).